- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01837875
Intervention to Improve Quality of Life in African American Lupus Patients (IQAN)
June 13, 2018 updated by: Medical University of South Carolina
Intervention to Improve Quality of Life for African-AmericaN Lupus Patients (IQAN)
The goal of the proposed project is to enhance the Principal Investigator's research ability to conduct behavioral interventions for people with lupus.
This includes intervention design, implementation, data collection and data analysis.
The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can improve quality of life, decrease indicators of depression, and reduce perceived and biological indicators of stress in African American lupus patients.
This study builds on three decades of work conducted in the field of arthritis self-management but differs in that the intervention mode, the disease (lupus), and the study population (African-Americans) are unstudied or understudied.
The IQAN Project will use the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) model as its theoretical framework.
This program has three specific aims.
The first aim seeks to design a three armed randomized, wait list controlled trial that employs a patient-centered 'a-la-carte' approach that offers subjects a variety of modes of interaction, allowing them to choose as many or few as they wish.
The second aim is to assess the intervention, using the RE-AIM model framework.
The third aim, to be achieved before the first aim, is to use previously collected data to characterize patient-centric barriers to care in African-American lupus patients, in order to identify trends in patient needs and desires, as well as correlates of non-response and non-compliance that can be used in the development and refinement of the intervention.
Study Overview
Status
Completed
Conditions
Detailed Description
The intervention will be coordinated by an Intervention Coordinator, with assistance from local/MUSC Study Coordinators.
A unique 'a-la-carte' self-management program will be offered to 50 African-American lupus patients participating in an ongoing SLE Clinic Database Project at MUSC.
The Intervention Coordinator will work with each participant in the intervention arm to create an individualized intervention plan (IIP).
Each IIP will include 1-4 options, including a mail-delivered arthritis kit, addition and access to a listserv, participation in a support group, and enrollment in local self-management program(s).
Due to the nature of the IIP, the proposed intervention will inherently vary by participant.
A 'set menu' control group of 50 lupus patients will be offered a standardized chronic disease self-management program only, and a control group of 50 lupus patients will receive usual care (UC), void of intervention components.
Validated measures of stress, depression, and quality of life will be collected in all patients in each condition before and after intervention activities.
To ensure intervention integrity, discrete components will follow written protocols and peer leaders will complete a standardized checklist for each session/encounter.
Study Type
Interventional
Enrollment (Actual)
153
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Columbia, South Carolina, United States, 29210
- Institute for Partnerships to Eliminate Health Disparities, University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- formal diagnosis of lupus
- Black or African American
Exclusion Criteria:
- Younger than 18 years
- CNS/neuropsychiatric lupus and/or dementia
- participation in a chronic disease self management program in the last 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Mailed informational literature
|
|
|
Active Comparator: Set Menu
Intervention: Enrollment in a local Chronic Disease Self-Management program (CDSMP) and monthly follow up calls to gauge progress and comfort
|
The Chronic Disease Self-Management Program (CDSMP) is a 2.5 hour workshop given weekly for six weeks.
People with different chronic health problems attend together and support one another in making positive changes in their health.
Workshops are facilitated by two trained leaders, one or both of whom are non-health professionals with a chronic disease themselves.
It is the process in which the program is taught that makes it effective.
Classes are highly participative, and mutual support builds the participants' confidence in their ability to manage their health and maintain active and fulfilling lives.
|
|
Experimental: Intervention
Intervention: Each individualized intervention plan (IIP) will include 1-4 options, including a mail-delivered arthritis kit, addition and access to a listserv, participation in a support group, and enrollment in local self-management program(s).
|
The Chronic Disease Self-Management Program (CDSMP) is a 2.5 hour workshop given weekly for six weeks.
People with different chronic health problems attend together and support one another in making positive changes in their health.
Workshops are facilitated by two trained leaders, one or both of whom are non-health professionals with a chronic disease themselves.
It is the process in which the program is taught that makes it effective.
Classes are highly participative, and mutual support builds the participants' confidence in their ability to manage their health and maintain active and fulfilling lives.
The Arthritis Self-Management Tool Kit contains 1) a "Self Test" to help participants determine how arthritis affects their lives and self-tailor the use of the Tool Kit, including items related to pain, fatigue, physical limitations, and health worries; 2) information sheets: Working with Your Doctor and the Health Care System; Exercise; Medications; Healthy Eating; Fatigue and Pain Management; Finding Community Resources; and Dealing with One's Emotions; 3) information sheets on key process components of the ASMP: Action Planning, Problem Solving, Deciding What to Try, and Individualizing an Exercise Program; 4) The Arthritis Helpbook; 5) audio relaxation and exercise compact discs (CDs); and 6) an audio CD of all material printed on the information sheets.
Interested participants will be referred to the "Lupus: Listening and Learning Group", a Charleston-based support group affiliated with the Lupus Foundation of America (LFA).
One to two LFA-trained facilitators implement the group.
The meeting format generally includes a specific discussion topic or an informative presentation such as by a medical or counseling professional, pharmacist, or lupus researcher.
This program is followed by time within the group for further interaction and support among the attendees who wish to participate.
The Lupus: Listening and Learning Group is open to all lupus patients, family members, friends and supporters, and there is no pre-registration or fee involved.
A project listserv will be established to link all intervention participants to facilitate exchange of coping strategies, pose questions, and share preferred educational resources or any other information relative to their everyday and disease-specific experiences and/or participation in the project.
Participants will be provided with a URL, from which they will be able to subscribe to the listserv.
Once subscribed, they will be able to post and receive messages, managed by a listserv moderator, who will be responsible for distribution to listserv members as appropriate.
Participants will have the option to unsubscribe at any time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of Life
Time Frame: Two years
|
Two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Disease Activity
Time Frame: Two years
|
Two years
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Stress
Time Frame: Two years
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2013
Primary Completion (Actual)
June 30, 2016
Study Completion (Actual)
August 31, 2016
Study Registration Dates
First Submitted
April 18, 2013
First Submitted That Met QC Criteria
April 22, 2013
First Posted (Estimate)
April 23, 2013
Study Record Updates
Last Update Posted (Actual)
June 15, 2018
Last Update Submitted That Met QC Criteria
June 13, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IQAN
- 1K01AR060026 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Chronic Disease Self-Management Program (CDSMP)
-
University of HaifaRecruitingChronic Disease | Kidney Transplantation | Cancer SurvivorshipIsrael
-
Washington University School of MedicineCompletedStroke | Chronic DiseaseUnited States
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedChronic DiseaseUnited States
-
University of GeorgiaYMCACompleted
-
Scott and White Hospital & ClinicTexas A&M UniversityCompleted
-
University of Missouri-ColumbiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
Emory UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Centers...Completed
-
VA Office of Research and DevelopmentCompleted
-
Kaiser PermanenteCompleted
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)CompletedDepressionUnited States